| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 12/16/2003 | US6663857 In vivo gene transfer using implanted retroviral producer cells |
| 12/16/2003 | US6663856 Gene therapy |
| 12/16/2003 | US6663659 Method and apparatus for the photomodulation of living cells |
| 12/16/2003 | CA2286879C Novel method for the production of anti-human antigen receptors and uses thereof |
| 12/16/2003 | CA2157114C Process for the preparation of 9-desoxotaxanes |
| 12/16/2003 | CA2134751C Monoclonal antibodies and their use |
| 12/16/2003 | CA2113894C A process for the preparation of demethylepypodophyllotoxin |
| 12/14/2003 | CA2432496A1 Diagnostic and therapeutic uses of sufu gene |
| 12/11/2003 | WO2003102588A2 Diagnostic agent, method for detecting a carcinoma, and means for the treatment thereof |
| 12/11/2003 | WO2003102584A2 Semaphorin-like proteins and methods of using same |
| 12/11/2003 | WO2003102576A1 POLYUBIQUITINATION OF RB CATALYZED BY Mdm2 |
| 12/11/2003 | WO2003102207A2 Novel multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments |
| 12/11/2003 | WO2003102188A1 Mutated androgen receptor, cancer cells expressing the same, method of constructing the same and use thereof |
| 12/11/2003 | WO2003102187A1 Self-coalescing or self-aggregating proteins derived from a membrane translocating sequence |
| 12/11/2003 | WO2003102180A1 NOVEL PEPTIDES HAVING cAMP PRODUCING ACTIVITY |
| 12/11/2003 | WO2003102151A2 Modulating cell differentiation and treating myeloprolifertive disorders with jnk/mkk inhibitors |
| 12/11/2003 | WO2003102148A2 Human prolactin antagonist-angiogenesis inhibitor fusion proteins |
| 12/11/2003 | WO2003102028A1 Rb1 gene induced protein (rb1cc1) and gene |
| 12/11/2003 | WO2003101996A2 Esters in position 20 of camptothecins |
| 12/11/2003 | WO2003101995A2 Camptothecins with a modified lactone ring |
| 12/11/2003 | WO2003101991A1 Xanthine phosphodiesterase v inhibitor polymorphs |
| 12/11/2003 | WO2003101989A1 Inhibitors of jak and cdk2 protein kinases |
| 12/11/2003 | WO2003101987A1 3-substituted quinuclidines and their use |
| 12/11/2003 | WO2003101985A1 2-oxo-1,3,4-trihydroquinazolinyl derivatives for the treatment of cell proliferation-related disorders |
| 12/11/2003 | WO2003101984A1 Substituted thiophenes, method for the production thereof, their use as a medicament or diagnostic reagent, and a medicament containing the same |
| 12/11/2003 | WO2003101980A1 1,3,5-triazine derivatives as ligands for human adenosine-a3 receptors |
| 12/11/2003 | WO2003101978A1 Phenyl-thiophene type vitamin d receptor modulators |
| 12/11/2003 | WO2003101970A1 Imidazolium cxcr3 inhibitors |
| 12/11/2003 | WO2003101951A2 Triptolide derivatives for modulation of apoptosis and immunosuppression |
| 12/11/2003 | WO2003101932A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 12/11/2003 | WO2003101927A1 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease |
| 12/11/2003 | WO2003101919A2 Scorpionate-like pendant macrocyclic ligands, complexes and compositions thereof, and methods of using same |
| 12/11/2003 | WO2003101530A2 Solid hydrogel coupling for ultrasound imaging and therapy |
| 12/11/2003 | WO2003101495A1 Methods and compositions for radioimmunotherapy of brain and cns tumors |
| 12/11/2003 | WO2003101491A1 PREVENTIVES AND/OR REMEDIES FOR SUBJECTS WITH THE EXPRESSION OR ACTIVATION OF Her2 AND/OR EGFR |
| 12/11/2003 | WO2003101486A2 Thermosensitive polymer carriers having a modifiable physical structure for biochemical analysis, diagnosis, and therapy |
| 12/11/2003 | WO2003101479A1 Compositions for therapeutic use comprising a vitamin, a metal salt and insulin or a growth hormone |
| 12/11/2003 | WO2003101475A1 Treatment of cell proliferative disorders with chlorotoxin |
| 12/11/2003 | WO2003101474A1 Combination chemotherapy with chlorotoxin |
| 12/11/2003 | WO2003101470A1 Pharmaceutical composition containing arsenic trioxide and at least one long-chain, polyunsaturated fatty acid |
| 12/11/2003 | WO2003101468A1 Method for the protection of endothelial and epithelial cells during chemotherapy |
| 12/11/2003 | WO2003101466A1 Rubrofusarin glycoside-containing composition |
| 12/11/2003 | WO2003101465A1 Novel solid preparation containing block copolymer and anthracycline anticancer agent and process for producing the same |
| 12/11/2003 | WO2003101456A1 Use of compounds that stimulate cgmp |
| 12/11/2003 | WO2003101455A2 Pharmaceutically active compounds having a tricyclic pyrazolotriazolopyrimidine ring structure and methods of use |
| 12/11/2003 | WO2003101453A1 Triple monoamine reuptake inhibitors for the treatment of chronic pain |
| 12/11/2003 | WO2003101451A1 Porphyrin oxygen infusion preparation for increasing oxygen concentration in tumor tissue |
| 12/11/2003 | WO2003101450A1 N- ((3-oxo2, 3-dihydro-1h-isoindol-1-yl) acetyl) guanidine derivatives as nhe-1 inhibitors for the treatment of infarction and angina pectoris |
| 12/11/2003 | WO2003101446A1 A herbal molecule as potential anti-leukemic drug |
| 12/11/2003 | WO2003101444A1 Diarylurea compounds and derivatives as chk-1 inhibitors for the treatment of cancer |
| 12/11/2003 | WO2003101425A2 Therapeutic agent-containing polymeric nanoarticles |
| 12/11/2003 | WO2003101406A1 Homo-camptothecin derivatives |
| 12/11/2003 | WO2003101386A2 Kinase suppressor of ras inactivation for therapy of ras mediated tumorigenesis |
| 12/11/2003 | WO2003101383A2 Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment |
| 12/11/2003 | WO2003101375A2 Immunostimulatory oligonucleotides and uses thereof |
| 12/11/2003 | WO2003101374A2 Use of new etonogestrel esters |
| 12/11/2003 | WO2003084984A8 Heterocyclic amides with alpha-4 integrin antagonist activity |
| 12/11/2003 | WO2003080566A3 Hif hydroxylase inhibitors |
| 12/11/2003 | WO2003074568A9 Individualized anti-cancer antibodies |
| 12/11/2003 | WO2003070265A3 Hedgehog-related prophylaxis, therapy and diagnosis of gi tract carcinogenesis |
| 12/11/2003 | WO2003064463A3 Pluripotency determining factors and uses thereof |
| 12/11/2003 | WO2003057666A3 Inhibitors of dipeptidyl peptidase iv |
| 12/11/2003 | WO2003051289A3 Solubilized topoisomerase poison agents |
| 12/11/2003 | WO2003048306A3 Polycistronic expression of antibodies |
| 12/11/2003 | WO2003044053A3 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 12/11/2003 | WO2003043632A3 Use of bisindolmaleimide and gemcitabine for the treatment of cancer |
| 12/11/2003 | WO2003040365A3 Pna-conjugate or pna-conjugate mixture for treating diseases related to the human papillomavirus |
| 12/11/2003 | WO2003038037A3 Glycogen synthase kinase function in endothelial cells |
| 12/11/2003 | WO2003037266A3 Tetra-, penta-, hexa- and heptapeptides having antiangiogenic activity |
| 12/11/2003 | WO2003035104A3 Compositions and methods for selected tumor treatment |
| 12/11/2003 | WO2003029825A3 Method for predicting the sensitivity to chemotherapy |
| 12/11/2003 | WO2003029407A3 Isolated nucleic acid molecules encoding a bacterial uracil transport protein and a bacterial uracil phosphoribosyl-transferase enzyme, cells transformed therewith and uses thereof |
| 12/11/2003 | WO2003028721A3 Substituted benzimidazole compounds and their use for the treatment of cancer |
| 12/11/2003 | WO2003027090A3 Bicyclic heterocycles as rxr ligands |
| 12/11/2003 | WO2003024926A3 Methods and compositions of novel triazine compounds |
| 12/11/2003 | WO2003024395A3 Linked biaryl compounds |
| 12/11/2003 | WO2003023042A9 Recombinant mva capable of expressing structural hcv antigens |
| 12/11/2003 | WO2003022883A3 Use of proteins for the production of a medicament for stimulating the innate non specific immune system |
| 12/11/2003 | WO2003022216A3 Biaryl substituted purine derivatives as potent antiproliferative agents |
| 12/11/2003 | WO2003018014A9 Methods of inhibiting formation of vascular channels and profileration using pyridinone derivatives |
| 12/11/2003 | WO2003017940A3 Pulsatile release compositions and methods for enhanced gastrointestinal drug absorption |
| 12/11/2003 | WO2003011895A8 Compositions and methods for modulation of immune responses |
| 12/11/2003 | WO2003011226A3 Products and drug delivery vehicles |
| 12/11/2003 | WO2003003975A3 Detection and therapy of vulnerable plaque with photodynamic compounds |
| 12/11/2003 | WO2003002142A8 Cancer vaccine containing cancer antigen based on tumor suppressor gene wt1 product and cationic liposomes |
| 12/11/2003 | WO2002094176A3 Use of compounds with combined nep/mp-inhibitory activity on the preparation of medicaments |
| 12/11/2003 | WO2002087508A3 Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use |
| 12/11/2003 | WO2002087465A3 Compositions and methods of double-targeting virus infections and cancer cells |
| 12/11/2003 | WO2002085925A3 Melanocortin receptor ligands |
| 12/11/2003 | WO2002083841A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 12/11/2003 | WO2002083067A3 Prodrugs via acylation with cinnamate |
| 12/11/2003 | WO2002081506A8 Process for producing trunkamide a compounds |
| 12/11/2003 | WO2002072013A3 Method of treating malignancies through induction of blood immune responses |
| 12/11/2003 | WO2002067986A3 Symbiotic regenerative agent |
| 12/11/2003 | WO2002064788A3 Compositions and methods relating to lung specific genes and proteins |
| 12/11/2003 | WO2002060383A3 Cancer therapy |
| 12/11/2003 | WO2002053149A3 Medicament containing a polyamine as an active substance |
| 12/11/2003 | WO2002048191A3 Inhibitory agents derived from specific growth factors |
| 12/11/2003 | WO2002048165A8 Antiviral agents for treatment of flaviviridae infections |
| 12/11/2003 | WO2002008174A8 Phenylethylamine derivatives and their use in the treatment of melanoma |